Presence of both Mesenchymal and Carcinomatous Features in an In-vitro Model of Ovarian Carcinosarcoma Derived from Patients' Ascitic Fluid

  • Ahmad Shariftabrizi Department of Pathology, Tufts University School of Medicine, Boston, MA 02111, USA.
  • Ilenia Pellicciotta Department of Radiation Oncology, New York University College of Medicine, New York, NY 10016, USA.
  • Amer Abdullah Department of Obstetrics, Gynecology and Reproductive Biology, Danbury Hospital, 24 Hospital Avenue, Danbury, CT 06810, USA.
  • Charis Anne Venditti Department of Obstetrics, Gynecology and Reproductive Biology, Danbury Hospital, 24 Hospital Avenue, Danbury, CT 06810, USA.
  • Robert Samuelson Department of Obstetrics, Gynecology and Reproductive Biology, Danbury Hospital, 24 Hospital Avenue, Danbury, CT 06810, USA.
  • Shohreh Shahabi Mail Department of Obstetrics, Gynecology and Reproductive Biology, Danbury Hospital, 24 Hospital Avenue, Danbury, CT 06810, USA.
Keywords:
#No Keywords#

Abstract

We have refined the technique for isolating and propagating cultures of primary ovarian carcinosarcoma cells (OSCs) derived from ascites, which allowed the cells to obtain the biphasic features of carcinosarcoma in cell culture conditions (presence of both carcinoma and mesenchymal morphologic types). This protocol involves a simple yet rapid method for the growth and propagation of ascites OSC in a basal culture medium. Autologous ascitic fluid was used as source of growth factors, and minimal manipulation was involved to establish the culture. The methodology allowed for the direct application of multiple molecular, cellular, and functional analyses within a few weeks of initial cell isolation, with the further potential of retrospective analyses of archived cells and tissues.

References

del Carmen MG, Birrer M, Schorge JO. Carcinosarcoma of the ovary: a review of the literature. Gynecol Oncol. 2012 Apr;125(1):271-77.

Cantrell LE, Van Le L. Carcinosarcoma of the ovary: a review. Obstet Gynecol Surv 2009;64:673–80.

Inthasorn P, Beale P, Dairymple C, et al. Malignant mixed mullerian tumour of the ovary: prognostic factor and response tof adjuvant platinum-based chemotherapy. Aust N Z J Obstet Gynaecol 2003;43:61–4.

Harris MA, Delap LM, Sengupta PS, et al. Carcinosarcoma of the ovary. Br J Cancer. 2003 Mar 10;88(5):654-7.

Lamb MR, Gertsen E, Middlemas E. Carcinosarcoma of the ovary: case report and literature review. Tenn Med. 2012 Mar;105(3):41-42.

Kurbacher CM, Korn C, Dexel S, et al. Isolation and culture of ovarian cancer cells and cell lines. Methods Mol Biolo. 2011: 731: 161-80.

Shepherd TG, Thériault BL, Campbell EJ, et al. Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc. 2006;1(6):2643-9.

Anastasia Malek and Oleg Tchernitsa (eds.), Ovarian Cancer: Methods and Protocols, Methods in Molecular Biology, vol. 1049, DOI 10.1007/978-1-62703-547-7_24, © Springer Science+Business Media New York 2013

Pellicciotta I1, Yang CP, Venditti CA, et al. Response to microtubule-interacting agents in primary epithelial ovarian cancer cells. Cancer Cell Int. 2013 Apr 10;13(1):33.

Ide Y, Nakahara T, Nasu M, et al. Establishment and characterization of the NEYS cell line derived from carcinosarcoma of human ovary withspecial reference to the susceptibility test of anticancer drugs. Hum Cell. 2009 Aug;22(3):72-80

van Haaften-Day C, Russell P, Carr S, et al. Development and characterization of a human cell line from an ovarian mixed Müllerian tumor (carcinosarcoma). In Vitro Cell Dev Biol. 1988 Oct;24(10):965-71.

Möbus VJ1, Gerharz CD, Weikel Wet al. Characterization of a human carcinosarcoma cell line of the ovary established after in vivo change of histologic differentiation. Gynecol Oncol. 2001 Dec;83(3):523-32.

How to Cite
1.
Shariftabrizi A, Pellicciotta I, Abdullah A, Venditti CA, Samuelson R, Shahabi S. Presence of both Mesenchymal and Carcinomatous Features in an In-vitro Model of Ovarian Carcinosarcoma Derived from Patients’ Ascitic Fluid. Int J Hematol Oncol Stem Cell Res. 9(1):1-4.
QRcode
Section
Articles